M. J. Löwik

发表

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

S. H. van der Burg, T. Stijnen, H. Hollema, 2016, Clinical Cancer Research.

Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity

S. H. van der Burg, G. Fleuren, G. Kenter, 2008, Clinical Cancer Research.

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

S. H. van der Burg, G. Fleuren, G. Kenter, 2013, Journal of Translational Medicine.

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

S. H. van der Burg, G. Fleuren, G. Kenter, 2008, Clinical Cancer Research.

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

J. M. van der Hulst, S. H. van der Burg, G. Fleuren, 2010, Proceedings of the National Academy of Sciences.

The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study

S. H. van der Burg, G. Fleuren, G. Kenter, 2014, Cancer Immunology, Immunotherapy.

A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

Marij J. P. Welters, S. H. van der Burg, G. Fleuren, 2012, Cancer Immunology, Immunotherapy.

An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer.

J. M. van der Hulst, S. H. van der Burg, G. Kenter, 2010, Cancer research.

Robust T-cell responses and clinical responses following long peptide vaccination against high risk HPV-16

G. Fleuren, G. Kenter, M. Welters, 2008 .

An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer

G. Kenter, M. Lowik, C. P. Maas, 2005, International Journal of Gynecologic Cancer.

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

G. Fleuren, G. Kenter, M. Welters, 2008, Clinical Cancer Research.